Kevin Zhang

Kevin Zhang is a Partner at Upfront Ventures, where involvement includes supporting early-stage investments in various technology sectors, particularly healthcare and fintech, since October 2012. Prior to this role, Kevin held positions as Principal, Senior Associate, and Associate at the same firm. In addition to ongoing work at Upfront Ventures, Kevin serves as Seed Lead and Board Member for multiple companies, including CertifyOS, Omni Creator Products, Pragma Platform, Switch Therapeutics, Path, Stray Bombay Company, Reveleer, Tellie, and Canvas Medical. Kevin Zhang obtained an AB in Biology with a minor in Psychology from Harvard University between 2005 and 2009.